Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2
0.010 AlteredExpression disease BEFREE CD133(+) Hep-2 laryngeal cancer cells are responsible for multidrug resistance due to elevated expression of ABCG2. 26353857 2016
Entrez Id: 176
Gene Symbol: ACAN
ACAN
0.010 AlteredExpression disease BEFREE Overall, the results of the present study show that ADAMTS-5/aggrecanase-2 is the main aggrecanase present in laryngeal carcinoma suggesting a critical role for the enzyme in aggrecan degradation and laryngeal tissue destruction during tumor progression. 23131589 2013
Entrez Id: 84680
Gene Symbol: ACCS
ACCS
0.010 GeneticVariation disease BEFREE Patients undergoing total laryngectomy alone for laryngeal cancer were identified from the ACS-NSQIP database from 2005 to 2014. 28000237 2017
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.010 AlteredExpression disease BEFREE RESULTS Our results demonstrate that ACE is over-expressed in laryngeal cancer and thus promotes cell proliferation. 27801393 2016
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3
0.010 AlteredExpression disease BEFREE The quantitative results showed that the CXCR7 mRNA levels were highest in laryngeal cancer and lowest in maxillary sinus carcinoma neoplasms, although there was no significant difference among the three samples. 26996902 2016
Entrez Id: 55902
Gene Symbol: ACSS2
ACSS2
0.010 GeneticVariation disease BEFREE Patients undergoing total laryngectomy alone for laryngeal cancer were identified from the ACS-NSQIP database from 2005 to 2014. 28000237 2017
Entrez Id: 100188795
Gene Symbol: AD11
AD11
0.010 Biomarker disease BEFREE Comparison of the binding affinities of Ad31, Ad11, Ad5, Ad37, Ad4 and Ad41, belonging to species A-F, respectively, to established cell lines of hepatoma (HepG2), breast cancer (CAMA and MG7), prostatic cancer (DU145 and LNCaP) and laryngeal cancer (Hep2), as well as to endothelial cells (HMEC), was carried out by flow cytometric analysis. 12604821 2003
Entrez Id: 102
Gene Symbol: ADAM10
ADAM10
0.010 Biomarker disease BEFREE Our findings indicated that ADAM10 serves a notable role in the progression and prognosis of laryngeal carcinoma. 28454261 2017
Entrez Id: 11096
Gene Symbol: ADAMTS5
ADAMTS5
0.010 Biomarker disease BEFREE Overall, the results of the present study show that ADAMTS-5/aggrecanase-2 is the main aggrecanase present in laryngeal carcinoma suggesting a critical role for the enzyme in aggrecan degradation and laryngeal tissue destruction during tumor progression. 23131589 2013
Entrez Id: 125
Gene Symbol: ADH1B
ADH1B
0.030 GeneticVariation disease BEFREE Alcohol-dehydrogenase (ADH1B) Arg48His polymorphism in Basque Country patients with oral and laryngeal cancer: preliminary study. 21378355 2011
Entrez Id: 125
Gene Symbol: ADH1B
ADH1B
0.030 GeneticVariation disease BEFREE However, ADH1B or ADH1C genotypes did not markedly modify the risk observed after stratification by alcohol consumption, and stratification by cumulative smoking exposure (in packyears) did not show an association of GSTM1 or GSTT1 genotype with laryngeal carcinoma either. 12668919 2003
Entrez Id: 125
Gene Symbol: ADH1B
ADH1B
0.030 GeneticVariation disease BEFREE Our data suggest that polymorphisms in ADH1B and CDH1 may be prognostic indicators in LC. 27689323 2016
Entrez Id: 126
Gene Symbol: ADH1C
ADH1C
0.020 GeneticVariation disease BEFREE However, ADH1B or ADH1C genotypes did not markedly modify the risk observed after stratification by alcohol consumption, and stratification by cumulative smoking exposure (in packyears) did not show an association of GSTM1 or GSTT1 genotype with laryngeal carcinoma either. 12668919 2003
Entrez Id: 126
Gene Symbol: ADH1C
ADH1C
0.020 GeneticVariation disease BEFREE The GSTmu(-) and ADH(3)1/ADH(3)1 genotypic combination may be a constitutional risk factor for laryngeal cancer among alcoholics. 9050916 1997
Entrez Id: 128
Gene Symbol: ADH5
ADH5
0.010 GeneticVariation disease BEFREE The GSTmu(-) and ADH(3)1/ADH(3)1 genotypic combination may be a constitutional risk factor for laryngeal cancer among alcoholics. 9050916 1997
Entrez Id: 79602
Gene Symbol: ADIPOR2
ADIPOR2
0.010 Biomarker disease BEFREE microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma. 25337209 2014
Entrez Id: 84740
Gene Symbol: AFAP1-AS1
AFAP1-AS1
0.020 AlteredExpression disease BEFREE Long non-coding RNA AFAP1-AS1 is an important tumor-associated lncRNA and its aberrant expression has been found in many malignancies so far, including pancreatic ductal adenocarcinoma, cholangiocarcinoma, gallbladder cancer, hepatocellular carcinoma, gastric cancer, colorectal cancer, esophageal cancer, nasopharyngeal carcinoma, lung cancer, ovarian cancer, breast cancer, retinoblastoma, laryngeal cancer, tongue squamous cell carcinoma and thyroid cancer. 30173945 2018
Entrez Id: 84740
Gene Symbol: AFAP1-AS1
AFAP1-AS1
0.020 Biomarker disease BEFREE We have been suggested that AFAP1-AS1 increases tumorigenesis in laryngeal carcinoma specifically by enhancing stemness and chemoresistance. 29971915 2018
Entrez Id: 102157402
Gene Symbol: AK6
AK6
0.010 AlteredExpression disease BEFREE Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer. 10506612 1999
Entrez Id: 10327
Gene Symbol: AKR1A1
AKR1A1
0.020 GeneticVariation disease BEFREE Alcohol-dehydrogenase (ADH1B) Arg48His polymorphism in Basque Country patients with oral and laryngeal cancer: preliminary study. 21378355 2011
Entrez Id: 10327
Gene Symbol: AKR1A1
AKR1A1
0.020 Biomarker disease BEFREE AKR1A1 induction was correlated with the radioresistant phenotype of laryngeal cancer HEp-2 cells. 22555805 2012
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.040 Biomarker disease BEFREE The aim of the present study was to investigate whether curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer through Bcl-2 and phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt), and by upregulating microRNA-15a (miR-15a). 29085504 2017
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.040 Biomarker disease BEFREE These findings revealed that miRNA-26b may play a key role in cell growth and death of laryngeal carcinoma through ULK2 and the PTEN/AKT pathway, and thus may be a new target for gene therapy in laryngeal carcinoma. 28713931 2017
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.040 Biomarker disease BEFREE Significant changes in protein and gene expression, including higher expression level of TrkB, were found in cells and laryngeal cancer specimens. we demonstrated that TrkB activates AKT via c-Src, leading to increased proliferation. 29312563 2017
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.040 Biomarker disease BEFREE From our data we conclude that FGFR1 and FGFR3, as well as its downstream regulatory PI3K/AKT kinases, may serve as potential biomarkers for the invasiveness and prognosis of laryngeal cancer. 29299828 2018